Intramuscular Temperature Modulates Glutamate-Evoked Masseter Muscle Pain Intensity in Humans

Aims: To determine whether glutamate-evoked jaw muscle pain is altered by the temperature of the solution injected. Methods: Sixteen healthy volunteers participated and received injections of hot (48°C), neutral (36°C), or cold (3°C) solutions (0.5 mL) of glutamate or isotonic saline into the masseter muscle. Pain intensity was assessed with an electronic visual analog scale (eVAS). Numeric rating scale (NRS) scores of unpleasantness and temperature perception, pain-drawing areas, and pressure pain thresholds (PPTs) were also measured. Participants filled out the McGill Pain Questionnaire (MPQ). Two-way or three-way repeated measures ANOVA were used for data analyses. Results: Injection of hot glutamate and cold glutamate solutions significantly increased and decreased, respectively, the peak pain intensity compared with injection of neutral glutamate solution. The duration of glutamate-evoked pain was significantly longer when hot glutamate was injected than when cold glutamate was injected. No significant effect of temperature on pain intensity was observed when isotonic saline was injected. No effect of solution temperature was detected on unpleasantness, heat perception, cold perception, area of pain drawings, or PPTs. There was a significantly greater use of the “numb” term in the MPQ to describe the injection of cold solutions compared to the injection of both neutral and hot solutions. Conclusion: Glutamate-evoked jaw muscle pain was significantly altered by the temperature of the injection solution. Although temperature perception in the jaw muscle is poor, pain intensity is increased when the muscle tissue temperature is elevated.

glutamate-evoked pain; musculoskeletal pain; pain assessment; temperature measurement

1. Hasselström J, Liu-Palmgren J, Rasjö-Wrååk G. Prevalence of pain in general practice. Eur J Pain 2002;6:375–385.

2. Hedenberg-Magnusson B, Ernberg M, Kopp S. Symptoms and signs of temporomandibular disorders in patients with fibro-myalgia and local myalgia of the temporomandibular system. A comparative study. Acta Odontol Scand 1997;55:344–349.

3. Brattberg G, Thorslund M, Wikman A. The prevalence of pain in a general population. The results of a postal survey in a county of Sweden. Pain 1989;37:215–222.

4. Dworkin SF, Huggins KH, LeResche L, et al. Epidemiology of signs and symptoms in temporomandibular disorders: Clinical signs in cases and controls. J Am Dent Assoc 1990;120:273–281.

5. John MT, Dworkin SF, Mancl LA. Reliability of clinical temporo-mandibular disorder diagnoses. Pain 2005;118:61–69.

6. LeResche L. Epidemiology of temporomandibular disorders: Implications for the investigation of etiologic factors. Crit Rev Oral Biol Med 1997;8:291–305.

7. Cairns BE, Dong X, Mann MK, et al. Systemic administration of monosodium glutamate elevates intramuscular glutamate levels and sensitizes rat masseter muscle afferent fibers. Pain 2007;132:33–41.

8. Dong XD, Mann MK, Kumar U, et al. Sex-related differences in NMDA-evoked rat masseter muscle afferent discharge re-sult from estrogen-mediated modulation of peripheral NMDA receptor activity. Neuroscience 2007;146:822–832.

9. Dong XD, Mann MK, Sessle BJ, Arendt-Nielsen L, Svensson P, Cairns BE. Sensitivity of rat temporalis muscle afferent fibers to peripheral N-methyl-D-aspartate receptor activation. Neuroscience 2006;141:939–945.

10. Cairns BE, Svensson P, Wang K, et al. Ketamine attenuates glutamate-induced mechanical sensitization of the masseter muscle in human males. Exp Brain Res 2006;169:467–472.

11. Cairns BE, Hu JW, Arendt-Nielsen L, Sessle BJ, Svensson P. Sex-related differences in human pain and rat afferent discharge evoked by injection of glutamate into the masseter muscle. J Neurophysiol 2001;86:782–791.

12. Castrillon EE, Cairns BE, Wang K, Arendt-Nielsen L, Svensson P. Comparison of glutamate-evoked pain between the temporalis and masseter muscles in men and women. Pain 2012; 153:823–829.

13. Castrillon EE, Cairns BE, Ernberg M, et al. Glutamate-evoked jaw muscle pain as a model of persistent myofascial TMD pain? Arch Oral Biol 2008;53:666–676.

14. Castrillon EE, Cairns BE, Ernberg M, et al. Effect of a peripheral NMDA receptor antagonist on glutamate-evoked masseter muscle pain and mechanical sensitization in women. J Orofac Pain 2007;2:216–224.

15. Svensson P, Graven-Nielsen T, Arendt-Nielsen L. Mechanical hyperesthesia of human facial skin induced by tonic painful stimulation of jaw muscles. Pain 1998;74:93–100.

16. Fujii Y, Ozaki N, Taguchi T, Mizumura K, Furukawa K, Sugiura Y. TRP channels and ASICs mediate mechanical hyperalgesia in models of inflammatory muscle pain and delayed onset muscle soreness. Pain 2008;140:292–304.

17. Lee J, Chung MK, Ro JY. Activation of NMDA receptors leads to phosphorylation of TRPV1 S800 by protein kinase C and A- Kinase anchoring protein 150 in rat trigeminal ganglia. Biochem Biophys Res Commun 2012;424:358–363.

18. Lee J, Saloman JL, Weiland G, Auh QS, Chung MK, Ro JY. Functional interactions between NMDA receptors and TRPV1 in trigeminal sensory neurons mediate mechanical hyperalgesia in the rat masseter muscle. Pain 2012;153:1514–1524.

19. Levine JD, Alessandri-Haber N. TRP channels: Targets for the relief of pain. Biochim Biophys Acta 2007;1772:989–1003.

20. Ro JY, Lee JS, Zhang Y. Activation of TRPV1 and TRPA1 leads to muscle nociception and mechanical hyperalgesia. Pain 2009; 144:270–277.

21. Szallasi A, Cruz F, Geppetti P. TRPV1: A therapeutic target for novel analgesic drugs? Trends Mol Med 2006;12:545–554.

22. Arendt-Nielsen L, Svensson P, Sessle BJ, Cairns BE, Wang K. Interactions between glutamate and capsaicin in inducing muscle pain and sensitization in humans. Eur J Pain 2008;12: 661–670.

23. Graven-Nielsen T, Arendt-Nielsen L, Mense S. Thermo-sensitivity of muscle: High-intensity thermal stimulation of muscle tissue induces muscle pain in humans. J Physiol 2002; 540:647–656.

24. Dworkin SF, LeResche L. Research diagnostic criteria for tem-poromandibular disorders. Review, criteria, examinations and specifications, critique. J Craniomandib Disord Facial Oral Pain 1992;6:301–355.

25. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160–170.

26. Arendt-Nielsen L, Curatolo M, Drewes A. Human experimental pain models in drug development: Translational pain research. CurrOpin Investig Drugs 2007;8:41–53.

27. Cairns BE, Svensson P, Wang K, et al. Activation of peripheral NMDA receptors contributes to human pain and rat afferent discharges evoked by injection of glutamate into the masseter muscle. J Neurophysiol 2003;90:2098–2105.

28. Cairns BE, Wang K, Hu JW, Sessle BJ, Arendt-Nielsen L, Svensson P. The effect of glutamate-evoked masseter muscle pain on the human jaw-stretch reflex differs in men and women. J Orofac Pain 2003;17:317–325.

29. Castrillon EE, Cairns BE, Ernberg M, et al. Effect of peripheral NMDA receptor blockade with ketamine on chronic myofascial pain in temporomandibular disorder patients: A randomized, double-blinded, placebo-controlled trial. J Orofac Pain 2008;22:122–130.

30. Schmelz M. Translating nociceptive processing into human pain models. Exp Brain Res 2009;196:173–178.

31. Svensson P, Wang K, Arendt-Nielsen L, Cairns BE, Sessle BJ. Pain effects of glutamate injections into human jaw or neck muscles. J Orofac Pain 2005;19:109–118.

32. Svensson P, Cairns BE, Wang K, et al. Glutamate-evoked pain and mechanical allodynia in the human masseter muscle. Pain 2003;101:221–227.

33. Svensson P, Graven-Nielsen T. Craniofacial muscle pain: Review of mechanisms and clinical manifestations. J Orofac Pain 2001;15:117–145.

34. Wang K, Sessle BJ, Svensson P, Arendt-Nielsen L. Glutamate evoked neck and jaw muscle pain facilitate the human jaw stretch reflex. Clin Neurophysiol 2004;115:1288–1295.

35. Drewes AM, Helweg-Larsen S, Petersen P, et al. McGill Pain Questionnaire translated into Danish: Experimental and clinical findings. Clin J Pain 1993;9:80–87.

36. Melzack R. The McGill Pain Questionnaire: Major properties and scoring methods. Pain 1975;1:277–299.

37. Ernberg M, Castrillon EE, Ghafouri B, et al. Experimental myalgia induced by repeated infusion of acidic saline into the human masseter muscle does not cause the release of algesic substances. Eur J Pain 2013;17:539–550.

38. Connor M, Naves LA, McCleskey EW. Contrasting phenotypes of putative proprioceptive and nociceptive trigeminal neurons innervating jaw muscle in rat. Mol Pain 2005;1:31.

39. Wang K, Arendt-Nielsen L, Svensson P. Capsaicin-induced muscle pain alters the excitability of the human jaw-stretch reflex. J Dent Res 2002;81:650–654.

40. Teodoro FC, Tronco Júnior MF, Zampronio AR, Martini AC, Rae GA, Chichorro JG. Peripheral substance P and neurokinin-1 receptors have a role in inflammatory and neuropathic orofacial pain models. Neuropeptides 2013;47:199–206.

41. Zhang H, Cang CL, Kawasaki Y, et al. Neurokinin-1 receptor enhances TRPV1 activity in primary sensory neurons via PKCepsilon: A novel pathway for heat hyperalgesia. J Neurosci 2007;27:12067–12077.

42. Cesare P, Dekker LV, Sardini A, Parker PJ, McNaughton PA. Specific involvement of PKC-epsilon in sensitization of the neuronal response to painful heat. Neuron 1999;23:617–624.

43. Koltzenburg M, Kress M, Reeh PW. The nociceptor sensitization by bradykinin does not depend on sympathetic neurons. Neuroscience 1992;46:465–473.

44. Kindgen-Milles D. Effects of prostaglandin E2 on the intensity of bradykinin-evoked pain from skin and veins of humans. Eur J Pharmacol 1995;294:491–496.

45. Schmelz M, Schmidt R, Weidner C, Hilliges M, Torebjork HE, Handwerker HO. Chemical response pattern of different classes of C-nociceptors to pruritogens and algogens. J Neurophysiol 2003;89:2441–2448.

46. Paterson KJ, Zambreanu L, Bennett DL, McMahon SB. Characterisation and mechanisms of bradykinin-evoked pain in man using iontophoresis. Pain 2013;154:782–792.

47. Esmann M, Skou JC. Temperature-dependencies of various catalytic activities of membrane-bound Na+/K+-ATPase from ox brain, ox kidney and shark rectal gland and of C12E8-solubilized shark Na+/K+-ATPase. Biochim Biophys Acta 1988;944:344–350.

48. Franssen H, Gebbink TA, Wokke JH, van den Berg LH, van Schelven LJ. Is cold paresis related to axonal depolarization?J Peripher Nerv Syst 2010;15:227–237.

49. Gordon TR, Kocsis JD, Waxman SG. Electrogenic pump (Na+/K(+)-ATPase) activity in rat optic nerve. Neuroscience 1990;37:829–837.

50. Hodgkin AL, Keynes RD. Active transport of cations in giant axons from Sepia and Loligo. J Physiol 1955;128:28–60.

51. Du S, Araki I, Kobayashi H, Zakoji H, Sawada N, Takeda M. Differential expression profile of cold (TRPA1) and cool (TRPM8)receptors in human urogenital organs. Urology 2008;72:450–455.

52. Harrington AM, Hughes PA, Martin CM, Yang J, Castro J, Isaacs NJ et al. A novel role for TRPM8 in visceral afferent function. Pain 2011;152:1459–1468.

53. Zerba E, Komorowski TE, Faulkner JA. Free radical injury to skeletal muscles of young, adult, and old mice. Am J Physiol 1990;258:C429–C435.

54. Brooks SV, Faulkner JA. Contraction-induced injury: Recovery of skeletal muscles in young and old mice. Am J Physiol 1990; 258:C436–C442.

55. Taguchi T, Matsuda T, Mizumura K. Change with age in muscular mechanical hyperalgesia after lengthening contraction in rats. Neurosci Res 2007;57:331–338.

56. Clarkson PM, Dedrick ME. Exercise-induced muscle damage, repair, and adaptation in old and young subjects. J Gerontol 1988;43:M91–M96.